X4 Pharmaceuticals, Inc.
ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE

Last updated:

Abstract:

Anti-RSV antibodies with neutralizing potency against RSV subtype A and RSV subtype B are provided, as well as methods for their identification, isolation, generation, and methods for their preparation and use are provided.

Status:
Application
Type:

Utility

Filling date:

20 Oct 2017

Issue date:

16 Jul 2020